Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease

Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease

The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is unresolved. Here, we used Florbetaben PET imaging to test for any association between cerebral amyloid deposition a...

Full description

Bibliographic Details
Main Authors: Tracy R. Melzer, Megan R. Stark, Ross J. Keenan, Daniel J. Myall, Michael R. MacAskill, Toni L. Pitcher, Leslie Livingston, Sophie Grenfell, Kyla-Louise Horne, Bob N. Young, Maddie J. Pascoe, Mustafa M. Almuqbel, Jian Wang, Steven H. Marsh, David H. Miller, John C. Dalrymple-Alford, Tim J. Anderson
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Neurology
Subjects:
Parkinson's disease
amyloid PET
Florbetaben
dementia
centiloid
mild cognitive impairment
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00391/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.00391/full

Similar Items